Skip to Main Content

Paper Details

Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.
Leukemia
12
2018
Author NameAffiliation
Stephen E KurtzKnight Cancer Institute, Oregon Health & Science University
Christopher A EideKnight Cancer Institute, Oregon Health & Science University
Christopher A EideHoward Hughes Medical Institute, Oregon Health & Science University
Andy KaempfKnight Cancer Institute, Oregon Health & Science University
Motomi MoriKnight Cancer Institute, Oregon Health & Science University
Motomi MoriOregon Health & Science University-Portland State University School of Public Health
Cristina E TognonKnight Cancer Institute, Oregon Health & Science University
Cristina E TognonHoward Hughes Medical Institute, Oregon Health & Science University
Uma BorateKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University
Brian J DrukerHoward Hughes Medical Institute, Oregon Health & Science University
Jeffrey W TynerKnight Cancer Institute, Oregon Health & Science University
  • 1 - 12

Datasets

Release 1.2